0001209191-18-018671.txt : 20180309
0001209191-18-018671.hdr.sgml : 20180309
20180309204655
ACCESSION NUMBER: 0001209191-18-018671
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20180306
FILED AS OF DATE: 20180309
DATE AS OF CHANGE: 20180309
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: KING RICHARD
CENTRAL INDEX KEY: 0001013702
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36399
FILM NUMBER: 18681714
MAIL ADDRESS:
STREET 1: C/O KOS PHARMACEUTICALS INC
STREET 2: 1001 BRICKELL AVE 25TH FL
CITY: MIAMI
STATE: FL
ZIP: 33131
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Adamas Pharmaceuticals Inc
CENTRAL INDEX KEY: 0001328143
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 421560076
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1900 POWELL ST., SUITE 750
CITY: EMERYVILLE
STATE: CA
ZIP: 94608
BUSINESS PHONE: 510-450-3554
MAIL ADDRESS:
STREET 1: 1900 POWELL ST., SUITE 750
CITY: EMERYVILLE
STATE: CA
ZIP: 94608
FORMER COMPANY:
FORMER CONFORMED NAME: NeuroMolecular Pharmaceuticals Inc
DATE OF NAME CHANGE: 20050524
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2018-03-06
0
0001328143
Adamas Pharmaceuticals Inc
ADMS
0001013702
KING RICHARD
C/O ADAMAS PHARMACEUTICALS, INC.
1900 POWELL ST., SUITE 750
EMERYVILLE
CA
94608
0
1
0
0
Chief Operating Officer
Common Stock
2018-03-06
4
A
0
11000
0.00
A
50661
D
Stock Option (Right to Buy)
25.66
2018-03-06
4
A
0
66000
0.00
A
2028-03-05
Common Stock
66000
66000
D
The shares of Common Stock are to be acquired upon the vesting of certain Restricted Stock Units granted to the Reporting Person. The Restricted Stock Units shall vest as follows: 25% of the total number of Restricted Stock Units will vest on each of March 20, 2019, March 20, 2020, March 20, 2021 and March 20, 2022, subject to Reporting Person's Continuous Service as of each such date.
The Option shares shall vest as follows: 1/48th of the option shares shall vest on the 1st of each month beginning with April 1, 2018, subject to Reporting Person's Continuous Service as of each such date.
/s/Jennifer Rhodes, as Attorney-in-Fact
2018-03-09